Adenocarcinoma of uterine cervix - Prognostic significance of clinicopathologic parameters

Croatian Medical Journal

Volumn 46, Issue 3, 2005, Pages 397-403

  Nola, Marin ^a,c   Tomičić, Ivana ^a   Dotlić, Snježana ^a   Morović, Anamarija ^a   Petrovečki, Mladen ^b   Jukić, Stanko ^a  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; MULTIVARIATE ANALYSIS; PLOIDY; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CROATIA; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 18844449353     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Clement PB, Young RH. Atlas of gynecologic surgical pathology. Philadelphia (PA): WB Saunders Company; 2000. p. 109-31.
2. Kurman JR, Norris HJ, Wilkinson E. Tumors of the cervix, vagina, and vulva. In: Rosat J, editor. Atlas of tumor pathology. Washington (DC): Armed Forces Institute of Pathology; 1992. p. 83-95.
3. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 5th ed. New York: Springer Verlag; 2002. p. 325-81.
4. Robboy SJ, Anderson MC, Russel P, Morse A. Cervix: malignant tumors. In: Robboy SJ, Anderson MC, Russel P, editors. Pathology of the female reproductive tract. London: Churchill Livingstone; 2002. p. 195-241.
5. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol. 2000;13:261-74.
6. Cohn DE, Peters WA 3rd, Muntz HG, Wu R, Greer BE, Tamimi HK, et al. Adenocarcinoma of the uterine cervix metastatic to lymph nodes. Am J Obstet Gynecol. 1998;178:1131-7.
7. Korhonen MO. Adenocarcinoma of the uterine cervix. Prognosis and prognostic significance of histology. Cancer. 1984;53:1760-3.
8. Pedersen D, Sogaard H, Overgaard J, Bentzen SM. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol. 1995;34: 787-95.
9. Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer. 2001;92:2471-83.
10. Costa MJ, McIlnay KR, Trelford J. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol. 1995;26:829-37.
11. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1996;63:304-11.
12. Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J, et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer. 2001;92:2999-3004.
13. Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer. 1997;80:1234-40.
14. Kaku T, Kamura T, Sakai K, Amada S, Kobayashi H, Shigematsu T, et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol. 1997;65:281-5.
15. Kristensen GB, Holm R, Abeler VM, Trope CG. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study. Gynecol Oncol. 1996;61:378-83.
16. Leminen A, Paavonen J, Vesterinen E, Forss M, Wahlstrom T, Kulomaa P, et al. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction. Am J Obstet Gynecol. 1990;162: 848-53.
17. Magtibay PM, Perrone JF, Stanhope CR, Katzmann JA, Keeney GL, Li H. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix. Gynecol Oncol. 1999;75:242-7.
18. McCormick SR, Peters AA, Schrauth JB. Flow cytometric DNA analysis with cytokeratin gating of formalin-fixed deparaffinized breast cancer nuclei. Am J Clin Pathol. 1998;110:227-37.
19. Krishan A, Oppenheimer A, You W, Dubbin R, Sharma D, Lokeshwar BL. Flow cytometric analysis of androgen receptor expression in human prostate tumors and benign tissues. Clin Cancer Res. 2000;6:1922-30.
20. Echeverri C, Fisher S, King D, Craig FE. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry. Am J Clin Pathol. 2002;117:615-20.
21. Kennedy GA, Cull G, Gill D, Marlton P, Morris D, Cobcroft R. Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: a heterogeneous group not necessarily of T cell origin. Pathology. 2002;34:46-50.
22. Nola M, Babic D, Ilic J, Marusic M, Uzarevic B, Petrovecki M, et al. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer. 1996;78:2543-50.
23. Vecek N, Nola M, Marusic M, Babic D, Uzarevic B, Sabioncello A, et al. Tumor cell cycle in patients with stage I endometrial carcinoma. Gynecol Oncol. 1994; 53:38-43.
24. Nola M, Babić D, Ilić J, Užarević B, Petrovečki M, Jukić S. Tumor cell cycle parameters in patients with stage I endometrial carcinoma. Croat Med J. 1995;36:249-52.
25. Kaspar HG, Dinh TV, Hannigan EV. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture. J Reprod Med. 1997; 42:170-2.
26. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983;31:1333-5.
27. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983;3:323-7.
28. Fu YS, Reagan JW, Hsiu JG, Storaasli JP, Wentz WB. Adenocarcinoma and mixed carcinoma of the uterine cervix. I. A. clinicopathologic study. Cancer. 1982;49: 2560-70.
29. Kristensen GB, Kaern J, Abeler VM, Hagmar B, Trope CG, Pettersen EO. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients. Gynecol Oncol. 1995;57:79-85.